» Articles » PMID: 32626935

Protective Effects of Combined Treatment with Mild Hypothermia and Edaravone Against Cerebral Ischemia/reperfusion Injury Via Oxidative Stress and Nrf2 Pathway Regulation

Overview
Journal Int J Oncol
Specialty Oncology
Date 2020 Jul 7
PMID 32626935
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Mild hypothermia (MH) and edaravone (EDA) exert neuroprotective effects against cerebral ischemia/reperfusion (I/R) injury through activation of the nuclear factor erythroid 2‑related factor 2 (Nrf2) pathway. However, whether MH and EDA exert synergistic effects against cerebral I/R injury remains unknown. The aim of the present study was to investigate the effects and mechanism of action of MH in combination with EDA in cerebral I/R injury. A rat cerebral I/R injury model was constructed by middle cerebral artery occlusion (MCAO) followed by reperfusion, and the mice were treated by MH, EDA or the inhibitor of the Nrf2 signaling pathway brusatol (Bru). It was observed that mice treated by MCAO had higher neurological deficit scores and oxidative stress levels, and low spatial learning and memory capacity; moreover, the CA1 region of the hippocampi of the mice exhibited reduced neuronal density and viability, and reduced mitochondrial dysfunction. However, MH in combination with EDA reversed the effects of MCAO, which were blocked by Bru injection. The levels of glutathione (GSH), GSH peroxidase, catalase and superoxide dismutase in rat ischemic hemisphere tissues were reduced by Bru. Western blotting demonstrated that the combined treatment with MH and EDA promoted the nuclear localization of Nrf2, and increased the levels of NAD(P)H quinone oxidoreductase and heme oxygenase (HO)‑1. In conclusion, MH combined with EDA exerted synergistic neuroprotective effects against cerebral I/R injury involving changes in the Nrf2/HO‑1 pathway.

Citing Articles

The protective effect of Edaravone against acute renocardiac syndrome in a kidney ischemia-reperfusion model.

Bagheri Y, Dehghan M, Hejazian S, Ardalan M, Zununi Vahed S, Niknafs B J Cardiovasc Thorac Res. 2025; 16(4):243-248.

PMID: 40027361 PMC: 11866771. DOI: 10.34172/jcvtr.33077.


Acute Administration of Edaravone Improves Cognitive Impairment in a Mouse Model of mPFC Ischemia: Crosstalk Between Necroptosis, Neuroinflammation, and Antioxidant Defense.

Barati A, Moghimi S, Taghavi Zanjani K, Rohani M, Sohrabi Hesar M, Arfaie A Mol Neurobiol. 2024; 62(4):4420-4434.

PMID: 39448519 DOI: 10.1007/s12035-024-04541-6.


Potential of Edaravone Dexborneol in the treatment of cerebral ischemia: focus on cell death-related signaling pathways.

Rahmati-Dehkordi F, Khanifar H, Zare-Hoseinabadi A, Dadgostar E, Jafarpour H, Aschner M Mol Biol Rep. 2024; 51(1):1007.

PMID: 39312062 DOI: 10.1007/s11033-024-09952-1.


A Systematic Review and Meta-Analysis of Therapeutic Hypothermia and Pharmacological Cotherapies in Animal Models of Ischemic Stroke.

Suerte A, Liddle L, Abrahart A, Khiabani E, Colbourne F Ther Hypothermia Temp Manag. 2024; 14(4):229-242.

PMID: 38946643 PMC: 11685787. DOI: 10.1089/ther.2024.0012.


Hypothermia increases adenosine monophosphate and xanthosine monophosphate levels in the mouse hippocampus, preventing their reduction by global cerebral ischemia.

Doshi M, Natori Y, Ishii A, Saigusa D, Watanabe S, Hosoyamada M Sci Rep. 2024; 14(1):3187.

PMID: 38326353 PMC: 10850059. DOI: 10.1038/s41598-024-53530-1.


References
1.
Xu F, Zhang G, Yin J, Zhang Q, Ge M, Peng L . Fluoxetine mitigating late-stage cognition and neurobehavior impairment induced by cerebral ischemia reperfusion injury through inhibiting ERS-mediated neurons apoptosis in the hippocampus. Behav Brain Res. 2019; 370:111952. DOI: 10.1016/j.bbr.2019.111952. View

2.
Dai H, Xu M, Lv J, Ji X, Zhu S, Ma R . Mild Hypothermia Combined with Hydrogen Sulfide Treatment During Resuscitation Reduces Hippocampal Neuron Apoptosis Via NR2A, NR2B, and PI3K-Akt Signaling in a Rat Model of Cerebral Ischemia-Reperfusion Injury. Mol Neurobiol. 2015; 53(7):4865-73. DOI: 10.1007/s12035-015-9391-z. View

3.
. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. PMC: 5605509. DOI: 10.1016/S0140-6736(17)32154-2. View

4.
Racay P, Tatarkova Z, Drgova A, Kaplan P, Dobrota D . Ischemia-reperfusion induces inhibition of mitochondrial protein synthesis and cytochrome c oxidase activity in rat hippocampus. Physiol Res. 2008; 58(1):127-138. DOI: 10.33549/physiolres.931383. View

5.
Tang X, Liu L, Koike M, Yenari M . Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke. Ther Hypothermia Temp Manag. 2013; 3(2):74-83. PMC: 3684213. DOI: 10.1089/ther.2013.0010. View